Back
GSK PLC Vs. Verona Pharma PLC Industry Stock Comparison
Sell
44
GLAXF
GSK PLC
Last Price:
16.83
Seasonality Move:
-1.62%
Buy
73
VRNA
Verona Pharma PLC
Last Price:
41.44
Seasonality Move:
12.05%
Sell
44
GSK PLC (GLAXF)
is a Sell
Is GSK PLC a Buy, Sell or Hold?
- The current GSK PLC [GLAXF] share price is $16.83. The Score for GLAXF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- GLAXF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Verona Pharma PLC (VRNA)
is a Buy
Is Verona Pharma PLC a Buy, Sell or Hold?
- The current Verona Pharma PLC [VRNA] share price is $41.42. The Score for VRNA is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- VRNA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $41.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
GLAXF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 44.35 | Sell |
| Chaikin Money Flow: | 4615 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.72 - 17.48) | Sell |
| Bollinger Bands (100): | (17.68 - 20.96) | Sell |
VRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 63.95 | Buy |
| Chaikin Money Flow: | 828080 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.28 - 40.44) | Buy |
| Bollinger Bands (100): | (25.55 - 37.35) | Buy |
GLAXF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.21 | Sell |
| 20-day SMA: | 17.02 | Sell |
| 50-day SMA: | 18.01 | Sell |
| 200-day SMA: | 20.08 | Sell |
| 8-day EMA: | 17.13 | Sell |
| 20-day EMA: | 17.24 | Sell |
| 50-day EMA: | 17.96 | Sell |
| 200-day EMA: | 19.32 | Sell |
VRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.08 | Buy |
| 20-day SMA: | 39.08 | Buy |
| 50-day SMA: | 36.52 | Buy |
| 200-day SMA: | 23.61 | Buy |
| 8-day EMA: | 40.03 | Buy |
| 20-day EMA: | 39.13 | Buy |
| 50-day EMA: | 36.36 | Buy |
| 200-day EMA: | 26.93 | Buy |
GSK PLC Earnings Growth & GLAXF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.
GSK PLC Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verona Pharma PLC Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||